Renaissance Technologies’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Renaissance Technologies’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-43,002	Closed	-$31.4K	–	3560
2026 Q1	$31.4K	Buy	+43,002	New	+$196K	﹤0.01%	3141
2025 Q4	–	Sell	-10,830	Closed	-$79.8K	–	3682
2025 Q3	$79.8K	Buy	+10,830	New	+$92K	﹤0.01%	3284
2023 Q3	–	Sell	-1,765	Closed	-$207K	–	4038
2023 Q2	$207K	Buy	1,765 +809	+85%	+$103K	﹤0.01%	3292
2023 Q1	$80K	Sell	956 -59	-6%	-$5.15K	﹤0.01%	3554
2022 Q4	$86K	Buy	+1,015	New	+$77.4K	﹤0.01%	3667
2022 Q3	–	Sell	-910	Closed	-$20K	–	4356
2022 Q2	$20K	Buy	910 +275	+43%	+$9.63K	﹤0.01%	4120
2022 Q1	$31K	Buy	+635	New	+$25.3K	﹤0.01%	3968
2021 Q3	–	Sell	-563	Closed	-$55K	–	3789
2021 Q2	$55K	Buy	+563	New	+$56.7K	﹤0.01%	3387

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Renaissance Technologies's RVPH Position: Q2 2026 in Review

Renaissance Technologies sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 43,002 shares — an estimated $31.4K sold.

Renaissance Technologies first reported a position in RVPH in Q2 2021 and held it in 8 quarters. The position peaked at $207K in Q2 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Renaissance Technologies reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Renaissance Technologies sold 43,002 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $31.4K.
Renaissance Technologies first reported a position in REVIVA PHARMA HLDGS INC in Q2 2021 and held it in 8 quarters.
Renaissance Technologies's REVIVA PHARMA HLDGS INC position peaked at $207K in Q2 2023.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.